Donor-transmitted bacterial infection in heart-lung transplantation.
Ciulli
F
F
Transplant Unit, Papworth Hospital, Cambridge, England.
Tamm
M
M
Dennis
C
C
Biocina
B
B
Mullins
P
P
Wells
F C
FC
Large
S R
SR
Wallwork
J
J
D000328:Adult; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy / Q000635:transmission*; D002442:Ceftazidime / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005436:Floxacillin / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology; D016041:Heart-Lung Transplantation / Q000009:adverse effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D012189:Retrospective Studies; D016896:Treatment Outcome
D005436:Floxacillin; D002442:Ceftazidime